1. Ahmed SF, Khwaja O, Hughes IA. The role of a clinical score in the assessment of ambiguous genitalia. BJU Int. 2000;85:120–4.
2. Bertelloni S, Baroncelli GI, Massart F, Toschi B. Growth in boys with 45,X/46,XY mosaicism: Effect of growth hormone treatment on statural growth. Sex Dev. 2015;9:183–9.
3. Cools M, Pleskacova J, Stoop H, Hoebeke P, Van Laecke E, Drop SL, et al. Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46,XY mosaicism. J Clin Endocrinol Metab. 2011;96:E1171–80.
4. De Groote K, Cools M, De Schepper J, Craen M, François I, Devos D, et al. Cardiovascular pathology in males and females with 45,X/46,XY mosaicism. PloS One. 2013;8:e54977.
5. Dumeige L, Chatelais L, Bouvattier C, De Kerdanet M, Hyon C, Esteva B, et al. Should 45,X/46,XY boys with no or mild anomaly of external genitalia be investigated and followed up? Eur J Endocrinol. 2018;179:181–90.